KOREAN
AI drug discovery
AI drug discovery
AI-Based Antibody Drug Development Service
Providing rapid and accurate antibody drug discovery using advanced AI technology.
Developing better therapeutics through innovative approaches.
Service Introduction
Gene On Biotech’s AI-based antibody drug development service offers a faster
and more efficient drug discovery process compared to traditional methods through data analysis,
machine learning, and simulations.
Drug Candidate Screening
Utilizing advanced AI technology
and extensive databases to quickly identify
the most promising antibody candidates.
Specific Epitope Selection
Select specific epitopes of a particular antigen to secure drugs
that not only demonstrate efficacy and safety
but also confirm the potential for patent registration.
Support for Development Tracks
– 96 sequences
– 96 plasmids
– 96 antibodies
– 96 cell lines
Technological Innovation
Revolutionizing traditional immunization and phage display methods by employing ML, RN, and GANs technologies.
1
High-Throughput Screening
AI swiftly identifies promising candidates from libraries of millions of compounds.
2
Structure-Based Design
Designing optimal molecular structures using 3D structural data of drug targets.
3
In Silico – In Vitro – In Vivo Integration
Connecting in silico discovered substances
with various in vitro validations and in vivo preclinical studies.
Leverage Advanced AI Technology at Reasonable Costs
Features
Applications
바텀 가로라인1
Inquiries and Consultations
For detailed information and customized consultations regarding
the AI-based antibody drug development service,
please feel free to contact us.
바텀 가로라인2
